Russian Federation: Medicaments Containing Hormones Market 2025

Medicaments Containing Hormones Market Size in the Russian Federation

The Russian medicaments containing hormones market totaled $X in 2022, remaining stable against the previous year. Overall, consumption continues to indicate a strong increase. Medicaments containing hormones consumption peaked at $X in 2017; however, from 2018 to 2022, consumption remained at a lower figure.

Medicaments Containing Hormones Production in the Russian Federation

In value terms, medicaments containing hormones production amounted to $X in 2022 estimated in export price. Over the period under review, production recorded a resilient expansion. The most prominent rate of growth was recorded in 2014 when the production volume increased by X%. Over the period under review, production hit record highs at $X in 2017; however, from 2018 to 2022, production stood at a somewhat lower figure.

Medicaments Containing Hormones Exports

Exports from the Russian Federation

After two years of decline, overseas shipments of medicaments containing hormones but not antibiotics decreased by X% to X kg in 2022. Overall, exports continue to indicate a sharp reduction. The growth pace was the most rapid in 2015 with an increase of X% against the previous year. As a result, the exports reached the peak of X tons. From 2016 to 2022, the growth of the exports failed to regain momentum.

In value terms, medicaments containing hormones exports shrank markedly to $X in 2022. Over the period under review, exports continue to indicate a abrupt slump. The pace of growth was the most pronounced in 2019 when exports increased by X%. Over the period under review, the exports reached the peak figure at $X in 2015; however, from 2016 to 2022, the exports failed to regain momentum.

Exports by Country

Belarus (X kg) was the main destination for medicaments containing hormones exports from Russia, accounting for a approx. X% share of total exports.

From 2012 to 2022, the average annual growth rate of volume to Belarus amounted to X%.

In value terms, Belarus ($X) also remains the key foreign market for medicaments containing hormones but not antibiotics exports from Russia.

From 2012 to 2022, the average annual rate of growth in terms of value to Belarus totaled X%.

Export Prices by Country

In 2022, the average medicaments containing hormones export price amounted to $X per ton, which is down by X% against the previous year. Over the period under review, the export price, however, posted a significant increase. The most prominent rate of growth was recorded in 2019 when the average export price increased by X%. The export price peaked at $X per ton in 2021, and then contracted dramatically in the following year.

As there is only one major export destination, the average price level is determined by prices for Belarus.

From 2012 to 2022, the rate of growth in terms of prices for Belarus amounted to X% per year.

Medicaments Containing Hormones Imports

Imports into the Russian Federation

In 2021, medicaments containing hormones imports into Russia fell significantly to X tons, which is down by X% on the year before. In general, imports, however, continue to indicate significant growth. The pace of growth appeared the most rapid in 2016 with an increase of X%. Imports peaked at X tons in 2017; however, from 2018 to 2021, imports remained at a lower figure.

In value terms, medicaments containing hormones imports reduced remarkably to $X in 2021. Overall, imports, however, recorded a significant expansion. The pace of growth was the most pronounced in 2016 with an increase of X% against the previous year. Over the period under review, imports reached the peak figure at $X in 2017; however, from 2018 to 2021, imports remained at a lower figure.

Imports by Country

France (X tons), Switzerland (X tons) and Germany (X kg) were the main suppliers of medicaments containing hormones imports to Russia, together accounting for X% of total imports.

From 2013 to 2021, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Switzerland (with a CAGR of X%), while imports for the other leaders experienced a decline.

In value terms, Switzerland ($X) constituted the largest supplier of medicaments containing hormones but not antibiotics to Russia, comprising X% of total imports. The second position in the ranking was taken by Germany ($X), with a X% share of total imports. It was followed by France, with a X% share.

From 2013 to 2021, the average annual rate of growth in terms of value from Switzerland stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (X% per year) and France (X% per year).

Import Prices by Country

The average medicaments containing hormones import price stood at $X per ton in 2021, increasing by X% against the previous year. In general, the import price showed a significant expansion. The pace of growth was the most pronounced in 2016 when the average import price increased by X%. The import price peaked at $X per ton in 2018; however, from 2019 to 2021, import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Germany ($X,272 per ton), while the price for France ($X per ton) was amongst the lowest.

From 2013 to 2021, the most notable rate of growth in terms of prices was attained by Switzerland (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :